US Stocks Movement | STAAR Surgical surges over 20% pre-market, Q1 net sales expected to double year-on-year

格隆汇2026/04/09 09:24

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Glonghui, April 9 | The leading company in the global field of refractive intraocular lenses saw its shares surge over 20% in pre-market trading. According to reports, the company announced its preliminary net sales for the first quarter ending April 3, 2026, projecting net sales for the first quarter of 2026 to exceed $90 million, compared to $42.6 million in the first quarter of 2025. Previously, analysts had expected Q1 revenue to be only $67.6 million, but the actual result of over $90 million significantly exceeded expectations.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Goldman Sachs' market value evaporated by several billions, with its share price down more than 22% from the year's high. Despite Q3 revenue exceeding expectations, a 41% drop in M&A activity and a slowdown in IPOs have dampened market sentiment. Analysts project a 12% revenue increase in Q4, but technical indicators suggest there is further downside risk to $783. Rumors about management transitions have also drawn attention.

智通财经•2026/10/12 03:52

Delivery soared by 85% but failed to prevent the death cross; Rivian (RIVN.US) dilution risk sparks panic

Despite the R2 model driving an 85% year-on-year increase in deliveries, Rivian's stock price continues to decline due to technical death cross, high short interest, and risks of equity dilution, facing a severe market test.

智通财经•2026/10/12 03:52